May 28 (Reuters) - Healthcare payments company Waystar

said on Tuesday it was targeting a valuation of up to $3.83

billion in its initial public offering in the United States.

Louisville, Kentucky-based Waystar joins a clutch of

companies looking to tap into improving investor appetite for

new listings amid increasing hopes of a soft landing for the

economy.

The company is aiming to raise up to $1.04 billion by

offering 45 million shares at a price range of $20 to $23

apiece.

Waystar will list on the Nasdaq Global Select Market under

the symbol "WAY".

J.P. Morgan Securities, Goldman Sachs and Barclays Capital

are the lead underwriters for the IPO.